检体有效性测试市场规模、份额、成长分析（按产品、类型、最终用户和地区）- 产业预测，2025 年至 2032 年

2023 年全球检体有效性测试市场规模为 24 亿美元，预计将从 2024 年的 25.6 亿美元成长到 2032 年的 42.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.5%。

随着职场、执法、医疗保健和体育等各个领域对准确、可靠和防篡改药物检测的需求日益增长，全球检体有效性检测市场正在经历显着增长。为了打击非法药物的使用，执法机构正在采用这些测试方法来识别可卡因和大麻等药物滥用。此外，政府对员工筛检的要求正在推动市场需求。技术进步发挥关键作用，人工智慧和机器学习等创新被用于开发检测异常检体的预测模型。此外，区块链技术正被用于追踪非法物质和防止篡改测试结果，而支援物联网的设备正在分析影响检体完整性的环境因素，最终提高测试过程的准确性和安全性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 案例研究

检体有效性测试市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 产品
  • 试剂、校正品和对照品
  • 检测试剂套件
  • 一次性的
• 服务

检体验证测试市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 实验室测试
• 快速/PoC 测试

检体有效性测试市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 职场
• 药物筛检实验室
• 刑事司法和执法
• 疼痛管理中心
• 戒毒中心
• 其他最终用户

检体验证测试市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Abbott.（US）
• Thermo Fisher Scientific Inc.（US）
• Puritan Medical Products（US）
• BD（US）
• Laboratory Corporation of America Holdings（US）
• Lucence Health Inc.（Singapore）
• Hardy Diagnostics（US）
• BTNX（Canada）
• Formlabs（US）
• Medline Industries, Inc.（US）
• VIRCELL SL（Spain）
• HiMedia Laboratories（India）
• Titan Biotech（India）
• McDermott Will & Emery（US）
• Miraclean Technology Co. Ltd（China）
• DiaSorin Molecular LLC（US）

结论和建议

Global Specimen Validity Testing Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.56 billion in 2024 to USD 4.23 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The global specimen validity testing market is witnessing significant growth driven by the increasing need for precise, reliable, and tamper-proof drug testing across various sectors, including workplace, law enforcement, healthcare, and sports. Law enforcement agencies employ these testing methods to identify substance abuse, including cocaine and marijuana, to combat illegal drug use. Furthermore, government mandates for employee screenings are propelling market demand. Technological advancements play a crucial role, with innovations such as artificial intelligence and machine learning used to develop predictive models for detecting abnormal specimens. Additionally, blockchain technology is employed for tracking illegal substances and preventing test result tampering, while IoT-enabled devices analyze environmental factors affecting specimen integrity, ultimately enhancing the accuracy and security of testing processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Specimen Validity Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Specimen Validity Testing Market Segments Analysis

Global Specimen Validity Testing Market is segmented by Product, Type, End User and region. Based on Product, the market is segmented into Products and Services. Based on Type, the market is segmented into Laboratory Testing and Rapid/PoC Testing. Based on End User, the market is segmented into Workplaces, Drug Screening Laboratories, Criminal Justice and Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Specimen Validity Testing Market

The Global Specimen Validity Testing market is primarily propelled by the increasing need for precise and dependable drug testing solutions. This rising demand is particularly evident in sectors such as sports drug testing, workplace testing, and the criminal justice system. Furthermore, heightened awareness regarding the adverse effects of drug use, coupled with the necessity for trustworthy testing methods, significantly contributes to the market's expansion. As organizations and institutions strive to ensure compliance and safety, the emphasis on effective specimen validity testing continues to grow, enhancing the industry's overall momentum and driving innovation within the sector.

Restraints in the Global Specimen Validity Testing Market

The Global Specimen Validity Testing market faces several constraints, primarily due to the high costs associated with the necessary equipment, reagents, and operational procedures. Laboratories must invest significantly in advanced tools and temperature monitoring devices to ensure the authenticity and accuracy of samples. These sophisticated instruments not only incur high initial procurement costs but also demand regular maintenance, calibration, and periodic replacement, adding to overall expenses. Additionally, the need for skilled and trained personnel to operate these systems escalates labor and training costs, creating further financial burdens for laboratories engaged in specimen validity testing.

Market Trends of the Global Specimen Validity Testing Market

The Global Specimen Validity Testing (SVT) market is witnessing a significant upward trend, fueled by advancements in diagnostic technology, including AI, machine learning, and the Internet of Things (IoT). These innovations enhance the effectiveness and user-friendliness of SVT, thereby bolstering confidence in drug testing across various sectors such as workplaces, healthcare, law enforcement, and sports. Furthermore, cutting-edge tools like biosensors and sophisticated chemical assays enable more precise detection of specimen adulteration, dilution, or substitution. As these technological developments continue to progress, the SVT market is poised for robust growth, meeting increasing demands for reliable and accurate testing solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Specimen Validity Testing Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Products
  • Reagents, Calibrators, and Controls
  • Assay Kits
  • Disposables
• Services

Global Specimen Validity Testing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Laboratory Testing
• Rapid/PoC Testing

Global Specimen Validity Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Workplaces
• Drug Screening Laboratories
• Criminal Justice and Law Enforcement Agencies
• Pain Management Centers
• Drug Rehabilitation Centers
• Other End Users

Global Specimen Validity Testing Market Size & CAGR (2025-2032)

• North America (Product & Service, Type, End User)
  • US
  • Canada
• Europe (Product & Service, Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucence Health Inc. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hardy Diagnostics (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTNX (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Formlabs (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIRCELL S.L. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Titan Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McDermott Will & Emery (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miraclean Technology Co. Ltd (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Molecular LLC (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations